Professor Zhengming Chen
Professor of Epidemiology and Director of China Programmes
- MRC PHRU Programme Leader
- Clinical Trial Service Unit and Epidemiological Studies Unit
Professor Zhengming Chen qualified in medicine at Shanghai Medical University in 1983 (now Fudan University), and gained his DPhil in Epidemiology at the University of Oxford in 1993. He was appointed as Professor of Epidemiology by the University of Oxford in 2006. He is now the Director of the China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) and co-executive director of the China Oxford Centre for International Health Research. His main researches focus on the environmental and genetic causes of chronic disease, evidence-based medicine and evaluation of widely practicable treatments for chronic diseases (such as IHD, stroke and cancer) as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has led several large randomised trials in heart disease (eg, COMMIT/CCS-2), stroke (eg, CAST) and cancer and 3 cohort studies involving >750,000 individuals. Since 2003 he has been the lead principal investigator in the UK for the China Kadoorie Biobank (CKB) prospective study of 0.5 million adults. He leads a research team in Oxford which is responsible for study design and development of procedures and IT systems for the CKB, and for central data management, curation and detailed analyses. He is an honorary professor of Peking Union Medical College and Fudan University in China.
Adherence to a healthy lifestyle and all-cause and cause-specific mortality in Chinese adults: a 10-year prospective study of 0.5 million people.
Zhu N. et al, (2019), Int J Behav Nutr Phys Act, 16
Vitamin D and calcium for the prevention of fracture: A systematic review and meta-analysis
YAO P. et al, (2019), JAMA Network Open
Association between environmental tobacco smoke exposure and risk of type 2 diabetes mellitus in Chinese female never-smokers: a population-based cohort study.
Huang C. et al, (2019), J Diabetes
Menopause and risk of hip fracture in middle-aged Chinese women: a 10-year follow-up of China Kadoorie Biobank
YAO P. et al, (2019), Menopause: The Journal of the North American Menopause Society
Parenthood and risk of hip fracture: a 10-year follow-up prospective study of middle-aged women and men in China
YAO P. et al, (2019), Osteoporosis International